Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Oates

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Drug Targets|January 29, 2008
Aldose reductase, still a compelling target for diabetic neuropathyPeter J Oates
Current Opinion in Investigational Drugs (London, England : 2000)|March 26, 2010
Aldose reductase inhibitors and diabetic kidney diseasePeter J Oates
International Review of Neurobiology|August 30, 2002
Polyol pathway and diabetic peripheral neuropathyPeter J Oates
Progress in Retinal and Eye Research|April 23, 2016
Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®)Peter F Kador, Milton Wyman, Peter J Oates
Diabetes|September 28, 2006
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathyWei Sun, Peter J Oates, James B Coutcher, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardiumYuying C Hwang, Soliman Bakr, Craig A Ellery, et al.
American Journal of Physiology. Renal Physiology|March 26, 2010
Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosisPing Xie, Lin Sun, Peter J Oates, et al.
Biochimica Et Biophysica Acta|March 8, 2008
High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathyBingmei Yang, Andrea Hodgkinson, Peter J Oates, et al.
Diabetes|February 28, 2003
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathyAndrea D Hodgkinson, Tracey Bartlett, Peter J Oates, et al.
Cardiovascular Diabetology|October 30, 2008
Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat heartsQing Li, Yuying C Hwang, Radha Ananthakrishnan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Drug Targets|January 29, 2008
Aldose reductase, still a compelling target for diabetic neuropathyPeter J Oates
Current Opinion in Investigational Drugs (London, England : 2000)|March 26, 2010
Aldose reductase inhibitors and diabetic kidney diseasePeter J Oates
International Review of Neurobiology|August 30, 2002
Polyol pathway and diabetic peripheral neuropathyPeter J Oates
Progress in Retinal and Eye Research|April 23, 2016
Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®)Peter F Kador, Milton Wyman, Peter J Oates
Diabetes|September 28, 2006
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathyWei Sun, Peter J Oates, James B Coutcher, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardiumYuying C Hwang, Soliman Bakr, Craig A Ellery, et al.
American Journal of Physiology. Renal Physiology|March 26, 2010
Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosisPing Xie, Lin Sun, Peter J Oates, et al.
Biochimica Et Biophysica Acta|March 8, 2008
High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathyBingmei Yang, Andrea Hodgkinson, Peter J Oates, et al.
Diabetes|February 28, 2003
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathyAndrea D Hodgkinson, Tracey Bartlett, Peter J Oates, et al.
Cardiovascular Diabetology|October 30, 2008
Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat heartsQing Li, Yuying C Hwang, Radha Ananthakrishnan, et al.
Pageof 3